Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma.

Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene. 2004 Feb 19; 23(7):1448-56.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.